David Bernstein
Pediatric Infectious Diseases · Cincinnati, OHNPI 1336163021
Payments from drug & device makers
Across 593 payments — averaging $3038.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$783K
- GSK$411K
- Gilead$211K
- Sanofi US Services Inc.$107K
- Chiesi USA, Inc.$82K
- Novartis$58K
- plus $150K from 22 others
Across 8 payments — averaging $1046.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$8K
What the payments were for
- Consulting fees$55,71083%
- Speaking & faculty fees$6,0009%
- Travel & lodging$3,3555%
- Food & beverage$2,3864%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 230 | $782,757 |
| GSK | 159 | $411,157 |
| Gilead | 2 | $210,563 |
| Sanofi US Services Inc. | 35 | $107,252 |
| Chiesi USA, Inc. | 24 | $82,071 |
| Novartis | 8 | $58,167 |
| Regeneron | 15 | $52,373 |
| Cipla USA Inc. | 4 | $28,839 |
| Modernatx, Inc. | 43 | $28,483 |
| Pfizer | 2 | $8,230 |
| Alk-abello, Inc | 9 | $8,119 |
| Dynavax Technologies Corporation | 7 | $6,863 |
| Aimmune Therapeutics, Inc. | 1 | $5,718 |
| Roche Diagnostics Corporation | 3 | $5,158 |
| Amgen | 2 | $2,651 |
| Sanofi Pasteur Inc. | 12 | $1,451 |
| Mirum Pharmaceuticals, Inc. | 1 | $770 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $198 |
| Sanofi | 4 | $171 |
| Teva Pharmaceuticals USA, Inc. | 6 | $156 |
| Regeneron Healthcare Solutions, Inc. | 3 | $136 |
| AstraZeneca | 8 | $125 |
| Covis Pharma GmbH | 2 | $44 |
| Kaleo, Inc. | 2 | $36 |
| Grifols USA, LLC | 2 | $35 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| AbbVie | 1 | $21 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUMENBA$8,100
- Odactra$8,018
- V160$6,027
- POC cobas Liat Analyzer, Assays, Controls and Accessories$5,158
- Heplisav-B$4,950
- NO PRODUCT DISCUSSED$1,217
- Livmarli$770
- DUPIXENT$101
How this compares
$1,801,582 in reported general payments places this provider in the 95th percentile of 43 pediatric infectious diseases providers in Ohio.
Other pediatric infectious diseases in Cincinnati
- Robert FrenckCincinnati$13.3M
- Grant PaulsenCincinnati$1.9M
- Lara Danziger-IsakovCincinnati$927K
- Mary StaatCincinnati$315K
- Elizabeth SchlaudeckerCincinnati$215K
- Rebecca BradyCincinnati$188K
- Sing Sing WayCincinnati$16K
- Mark MurphyCincinnati$322
- David HaslamCincinnati$127
- Samir ShahCincinnati$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.